Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06531733 · ClinicalTrials.gov registry record · NA
Artemis Sleep Countermeasures
A NA study of Fatigue, sponsored by National Aeronautics and Space Administration (NASA).
- Recruiting
- Registry status
- NA
- Development phase
- 24
- Enrollment target
- 1
- Study location
NCT06531733 is a NA study of Fatigue that is actively recruiting participants, run by National Aeronautics and Space Administration (NASA). The registered enrollment target is 24 participants, below the 218-participant average among 109 other Fatigue trials with a reported enrollment target (89% lower). The trial reports 1 study location across 1 state.
The verdict
NCT06531733, a NA study of Fatigue, is actively recruiting participants, sponsored by National Aeronautics and Space Administration (NASA).
- RECRUITING
- Registry status
- NA
- Development phase
- 24 participants
- Enrollment target
- 1
- Study location
Study Summary
Purpose. The purpose of this study is to test sleep and wake-promoting countermeasures to evaluate their effectiveness in helping individuals fall asleep quickly, maintain sleep during a nap, and maintain alertness during waking. Protocol Overview. The proposed study involves two laboratory visits separated by at least one week. Participants are required to complete all procedures in the companion screening and at-home protocol in order to qualify for this laboratory protocol. The at-home protocol involves keeping a regular schedule for 2-3 weeks. Participants will need to maintain a regular schedule with at least 8.5 hours in bed for at least one week prior to the first laboratory visit. They will then continue the at-home protocol, maintaining at least 8.5 hours in bed each night for at least a week before completing the second laboratory visit. There are two interventions that participants will experience during the study, sleep promoting (pink noise) and wake promoting (blue enriched lighting plus a nap). These will be delivered separately and together depending on randomization. Participants will first be randomized to one of three conditions sleep promoting + wake placebo, sleep placebo + wake promoting, or sleep promoting + wake promoting. All participants will complete a sleep placebo + wake placebo condition. The order of the full placebo condition versus the intervention (i.e., lab visit 1 vs. lab visit 2) will be randomized after the condition randomization occurs. Each participant will complete one of the interventions and one placebo for a total of two visits.
Conditions Studied
Interventions
- DEVICE Sleep Promoting (pink noise)
- DEVICE Wake Promoting (blue enriched light plus a nap)
Study Locations (1)
California
- NASA Ames Research Center - Mountain View
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 24 participants |
| Start Date | 2024-06-22 |
| Est. Completion | 2025-06-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06531733
The ClinicalTrials.gov registry entry for NCT06531733 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 24 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 218-participant average among 109 other Fatigue trials with a reported enrollment target (89% lower). The listed sponsor is National Aeronautics and Space Administration (NASA), which has 8 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Fatigue appearing as the primary indexed condition, and to 2 interventions - of which Sleep Promoting (pink noise) is the first listed.
NCT06531733 reports 1 study location spanning 1 distinct geographic area - top geographies include California.
Frequently Asked Questions
What is clinical trial NCT06531733 about?
NCT06531733 is a clinical study titled "Artemis Sleep Countermeasures". Purpose. The purpose of this study is to test sleep and wake-promoting countermeasures to evaluate their effectiveness in helping individuals fall asleep quickly, maintain sleep during a nap, and maintain alertness during waking. Protocol Overview. The proposed study involves two laboratory visits ...
What is the current status of trial NCT06531733?
This trial is currently recruiting. It is a NA study. The enrollment target is 24 participants. The study started on 2024-06-22. Estimated completion is 2025-06-01.
What conditions does trial NCT06531733 study?
This clinical trial studies the following conditions: Fatigue.
What interventions are being tested in trial NCT06531733?
The interventions under investigation include: Sleep Promoting (pink noise) (DEVICE), Wake Promoting (blue enriched light plus a nap) (DEVICE).
Who is sponsoring clinical trial NCT06531733?
This trial is sponsored by National Aeronautics and Space Administration (NASA), which has 8 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06531733 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Fatigue
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Fatigue and Cognitive Demand With Aging
RECRUITING · NA
-
Behavioral and Neural Correlates of Post-Stroke Fatigue
RECRUITING · NA
-
Cancer-related Fatigue and Its Biological Contributors in Adolescent and Young Adult Brain Tumor Survivors: Effects of a Tele-exercise Intervention
RECRUITING · NA
-
The Fit With Us Study
RECRUITING · NA
-
Increasing Physical Activity for Adults With Multiple Sclerosis (MS)
RECRUITING · NA
-
Lifting More Than Weights: Resistance Exercise Program Across Socioeconomic Groups for Cancer-Related Fatigue Management
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.